Former Biopharmaceutical Executive Found Liable for ‘Shadow Trading’ in Landmark Insider Trading Case
SAN FRANCISCO (AP) — A former biopharmaceutical executive was found liable for “shadow trading,” an insider trading theory, by a federal jury in San Francisco on Friday. The jury’s decision rejected the defense’s claim that the case was constructed by the U.S. Securities and Exchange Commission (SEC) without evidence of the motives behind the trades. This verdict could have significant implications for insider trading regulations. Matthew Panuwat, the defendant, was accused by the SEC of having confidential information about his employer, Medivation Inc., and trading in the securities of Incyte Corp., a closely related company. … Read more